The purpose of the International Congress of Parkinson’s Disease and Movement Disorders in Vancouver is to offer a forum for clinical and basic science discussion on a variety of movement disorder topics, including presentations of current research and available treatments.
Through state-of-the-art lectures, hot topic reviews, controversy debates, teaching courses, skills workshops and video sessions, participants will be better able to:
1. Describe the pathophysiology and neurobiology of Parkinson’s disease and other movement disorders;
2. Discuss the diagnostic approaches and tools available for Parkinson’s disease and other movement disorders;
3. Discuss the pharmacological and non-pharmacological treatment options available for Parkinson’s disease and other movement disorders.
The International Parkinson and Movement Disorder Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. ACCME accreditation covers the following accreditation bodies through a reciprocity agreement:
Canada: CPD activities held in Canada developed by accredited CPD physician organizations recognized by the Accreditation Council for Continuing Medicine Education are deemed to be Accredited Group Learning Activities (Section1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
EACCME: The UEMS-EACCME® and the AMA recognize each other’s CME credits since 2000. In 2014 the UEMS-EACCME® and the AMA renewed an agreement that European physicians can earn their ECMEC®s worldwide, except in Europe, that have been certified for AMA PRA Category 1 Credits™. For further information on reciprocity, please see the AMA website.
The International Parkinson and Movement Disorder Society designates this live activity for a maximum of 35 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
The target audience of the 21st International Congress of Parkinson’s Disease and Movement Disorders includes clinicians, researchers, post-doctoral fellows, medical residents, medical students and other healthcare professionals with an interest in the current research and approaches for the diagnosis and treatment of movement disorders.
It is the policy of The International Parkinson and Movement Disorder Society (MDS) to ensure balance, independence, objectivity and scientific rigor in all sponsored educational activities. All persons in control of content, including: planners, faculty and reviewers, participating in any MDS sponsored activities are required to disclose to the activity audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the Continuing Medical Education (CME) activity. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations who have products or services regardless of presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation but to ensure that the speaker can present independent of their financial interest. Any potential conflict should be identifed openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts. It remains for the audience to determine whether the speaker’s outside interest may reject a possible bias in either the exposition or the conclusions presented.
All financial disclosure information will be available to participants in Vancouver at the MDS membership booth and on the International Congress website.
All CME Sessions:
Please see the MDS International Congress App for all CME Session evaluations. Evaluations are considered part of the course.